← Back to Search

Behavioral Intervention

Telemedicine ICU Recovery Clinic for Post Intensive Care Syndrome (TelePORT Trial)

N/A
Recruiting
Led By Leanne M Boehm, PhD
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

TelePORT Trial Summary

This trial focuses on studying the long-term cognitive impairment in patients after they have been in intensive care. The study aims to understand how this impairment affects patients' ability to live independently, work, and manage

Who is the study for?
This trial is for adults over 45 who were in a medical or surgical ICU, treated for acute respiratory failure with mechanical ventilation and/or septic shock with vasopressors. It's not suitable for those who don't meet these specific conditions.Check my eligibility
What is being tested?
The TelePORT Study is testing the use of telemedicine visits to help patients recover cognitive skills after intensive care. It aims to see if this can improve their ability to live independently and manage daily tasks.See study design
What are the potential side effects?
Since the intervention involves telehealth visits rather than medication, there are no direct physical side effects expected from participating in this study.

TelePORT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive function - MoCA
Cognitive function - PROMIS
Secondary outcome measures
Mental health - PTSD
Mental health - anxiety/depression
Physical function - ADL
+4 more
Other outcome measures
Post-Traumatic Growth

TelePORT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine ICU Recovery ClinicExperimental Treatment1 Intervention
scheduled telemedicine study visits 3 weeks and 3 months after hospital discharge or return-to-home if discharged to another facility
Group II: Standard Recovery Conditions (i.e., Control)Active Control1 Intervention
Control group participants will proceed with follow-up as determined by the discharging hospital team and directed to use the provided PICS guide to connect with commonly used resources.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,683 Total Patients Enrolled
Vanderbilt UniversityLead Sponsor
704 Previous Clinical Trials
6,143,161 Total Patients Enrolled
Ohio State UniversityOTHER
830 Previous Clinical Trials
505,418 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of individuals participating in this clinical trial?

"Indeed, information available on clinicaltrials.gov shows that this study is actively seeking participants. Originally shared on February 14th, 2024, the trial was last updated on February 28th, 2024. A total of 202 individuals will be enrolled in the research across two designated sites."

Answered by AI

Are potential participants currently being accepted for this ongoing medical study?

"As per clinicaltrials.gov, this research is presently in search of volunteers. The trial was first made public on February 14th, 2024 and last revised on February 28th, 2024."

Answered by AI
~135 spots leftby Nov 2027